Serving hundreds of leading biopharmaceutical companies globally:

Generated: November 18, 2018

DrugPatentWatch Database Preview

Mylan Ireland Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for MYLAN IRELAND LTD, and what generic and branded alternatives to MYLAN IRELAND LTD drugs are available?

MYLAN IRELAND LTD has eight approved drugs.

Summary for Mylan Ireland Ltd

US Patents:	0
Tradenames:	6
Ingredients:	6
NDAs:	8

Drugs and US Patents for Mylan Ireland Ltd

+ Get email alerts for changes to this table

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mylan Ireland Ltd	CARBAMAZEPINE	carbamazepine	CAPSULE, EXTENDED RELEASE;ORAL	076697-002	May 20, 2011	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Mylan Ireland Ltd	MIACALCIN	calcitonin salmon	INJECTABLE;INJECTION	017808-001	Jul 3, 1986		DISCN	No	No		➤ Sign Up				➤ Sign Up
Mylan Ireland Ltd	CARBAMAZEPINE	carbamazepine	CAPSULE, EXTENDED RELEASE;ORAL	076697-003	May 20, 2011	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Mylan Ireland Ltd	MIACALCIN	calcitonin salmon	INJECTABLE;INJECTION	017808-002	Mar 29, 1991		RX	Yes	Yes		➤ Sign Up				➤ Sign Up
Mylan Ireland Ltd	ARIXTRA	fondaparinux sodium	INJECTABLE;SUBCUTANEOUS	021345-002	May 28, 2004	AP	RX	Yes	Yes		➤ Sign Up				➤ Sign Up
Mylan Ireland Ltd	SUCRALFATE	sucralfate	TABLET;ORAL	074415-001	Jun 8, 1998		DISCN	No	No		➤ Sign Up				➤ Sign Up
Mylan Ireland Ltd	MIACALCIN	calcitonin salmon	SPRAY, METERED;NASAL	020313-002	Aug 17, 1995		DISCN	Yes	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Expired US Patents for Mylan Ireland Ltd

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Mylan Ireland Ltd	ARIXTRA	fondaparinux sodium	INJECTABLE;SUBCUTANEOUS	021345-001	Dec 7, 2001	4,818,816	➤ Sign Up
Mylan Ireland Ltd	MIACALCIN	calcitonin salmon	SPRAY, METERED;NASAL	020313-002	Aug 17, 1995	5,759,565	➤ Sign Up
Mylan Ireland Ltd	MIACALCIN	calcitonin salmon	SPRAY, METERED;NASAL	020313-002	Aug 17, 1995	5,733,569	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon

Farmers Insurance

Moodys

Harvard Business School

Merck

Dow

Medtronic

Daiichi Sankyo

Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.